These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9503214)

  • 1. Clinical effect of propiverine in patients with urge or stress incontinence. Kobe University Incontinence Study Group.
    Okada H; Sengoku J; Gohji K; Arakawa S; Kamidono S
    Hinyokika Kiyo; 1998 Jan; 44(1):65-9. PubMed ID: 9503214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of clenbuterol and propiverine in menopausal women with urinary incontinence: improvement in quality of life.
    Ushiroyama T; Ikeda A; Ueki M
    J Med; 2000; 31(5-6):311-9. PubMed ID: 11508324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the symptoms of urinary urge and urge incontinence with propiverin hydrochloride (Mictonorm)].
    Blau U; Retzke U
    Zentralbl Gynakol; 1984; 106(14):981-7. PubMed ID: 6506904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
    Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
    Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence.
    Madersbacher H; Halaska M; Voigt R; Alloussi S; Höfner K
    BJU Int; 1999 Oct; 84(6):646-51. PubMed ID: 10510109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
    Mazur D; Göcking K; Wehnert J; Schubert G; Herfurth G; Alken RG
    Urologe A; 1994 Sep; 33(5):447-52. PubMed ID: 7974935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.
    Alloussi S; Mürtz G; Braun R; Gerhardt U; Heinrich M; Hellmis E; Horn W; Marschall-Kehrel D; Niklas K; Raabe M; Rössler T; Seibt B; Siemer S; Schultz-Lampel D; Walter H; Wiedeking B; Alloussi S; Bock P; Strugala G; Madersbacher H
    BJU Int; 2010 Aug; 106(4):550-6. PubMed ID: 20002668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propiverine versus tolterodine: efficacy and tolerability in patients with overactive bladder.
    Jünemann KP; Halaska M; Rittstein T; Mürtz G; Schnabel F; Brünjes R; Nurkiewicz W
    Eur Urol; 2005 Sep; 48(3):478-82. PubMed ID: 15967567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of detrusor hyperactivity and increased sensitivity and irritability of the urinary bladder: results of a study monitoring drug utilization].
    Halaska M; Martan A; Voigt R; Kaplan F; Raus K; Masata J; Klemenc J
    Ceska Gynekol; 1997 Oct; 62(5):259-64. PubMed ID: 9600163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes induced by Mictonorm in the urodynamics of the detrusor muscle in females with symptoms of the urge to urinate].
    Höfner K; Dorschner W; Höfner T; Dieterich F
    Z Urol Nephrol; 1985 Jul; 78(7):363-70. PubMed ID: 4050155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
    Schulte-Baukloh H; Mürtz G; Henne T; Michael T; Miller K; Knispel HH
    BJU Int; 2006 Feb; 97(2):355-8. PubMed ID: 16430646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.